Genes, Mutations and Fine-Structure Analysis
Alleles, pseudoalleles, complementation and the cistron; mutation types, causes and detection; dominant-negative alleles; Benzer's rII fine-structure mapping.
- 24 min
On this page · 17 sections
- Prerequisites
- The Hook: Resistant Bacteria That Were Already There
- Alleles, Multiple Alleles and Pseudoalleles
- The Complementation Test
- Kinds of Mutation
- Why Mutations Are Dominant or Recessive
- Causes of Mutation
- Detecting Mutations
- Mutation Rate vs Mutation Frequency
- Fine-Structure Mapping: Benzer and the rII Locus
- Memory Tricks
- Don’t Confuse
- Common Mistakes
- Practice
- Quick Revision Table
- Key Takeaways
- What’s Next
Prerequisites
- Mendelian and Extrachromosomal Inheritance — dominance, multiple alleles and the test cross are assumed.
- DNA Replication, Repair and Recombination — polymerase fidelity, mismatch repair, NER and the SOS response decide which lesions become mutations.
- Translation, Protein Processing and Degradation — the genetic code, stop codons and suppressor tRNAs.
The Hook: Resistant Bacteria That Were Already There
Alleles, Multiple Alleles and Pseudoalleles
| Term | Meaning |
|---|---|
| Gene (locus) | A heritable unit at a fixed chromosomal position; at the molecular level, a DNA segment encoding a functional product with its regulatory regions |
| Allele | An alternative form of a gene at the same locus |
| Wild-type allele | The allele common in natural populations or the reference stock (written + ) |
| Multiple alleles | More than two alleles of one gene exist in the population (ABO; rabbit c series; Drosophila white series) |
| Isoalleles | Alleles that give the same phenotype under ordinary conditions but differ in sequence or under special conditions |
| Pseudoalleles | Mutations that behave as alleles in a complementation test (the trans heterozygote is mutant) but can be separated by recombination, so they occupy different sites |
Pseudoallelism and the cis–trans position effect
Classical pseudoalleles were first recognised in Drosophila (the lozenge eye locus; Star and asteroid; later the bithorax complex studied by E. B. Lewis). Two mutations a and b that are tightly linked show:
| Arrangement | Genotype | Phenotype |
|---|---|---|
| Trans (repulsion) | a + / + b | Mutant (no complementation) |
| Cis (coupling) | a b / + + | Wild type |
Rare crossing over between a and b produces a b and + + chromosomes, which is how the two sites were shown to be separate. The different phenotypes of cis and trans arrangements of the same two mutations is the cis–trans position effect. Once DNA sequencing was possible, most “pseudoalleles” were understood as mutations at different sites within one gene (the expected situation for any gene, since any two point mutations in a gene can recombine) or as closely linked genes with related functions in a gene complex.
The Complementation Test
The complementation (cis–trans) test asks whether two recessive mutations with the same phenotype lie in the same gene or in different genes. Put the two mutations together in trans in one cell or organism (a diploid, a heterokaryon, a merodiploid or a mixed phage infection):
- Wild-type phenotype → complementation → different genes. Each genome supplies the product that the other lacks.
- Mutant phenotype → no complementation → same gene (both copies of that product are defective).
graph TD
A["Two recessive mutants
with the same phenotype"] --> B["Combine in trans:
m1 + / + m2"]
B --> C{"Phenotype?"}
C -->|"Wild type"| D["Complementation:
different genes
(different cistrons)"]
C -->|"Mutant"| E["No complementation:
same gene
(same cistron)"]The control is the cis configuration (m1 m2 / + +), which must be wild type; it shows that the mutations are recessive. A cistron (Benzer’s term) is the unit defined by this test: the stretch of DNA within which two mutations in trans fail to complement.
Building complementation groups from a matrix
Read the matrix as a graph: mutations that fail to complement each other (–) belong to one group.
| 1 | 2 | 3 | 4 | 5 | 6 | |
|---|---|---|---|---|---|---|
| 1 | – | + | – | + | + | – |
| 2 | – | + | – | + | + | |
| 3 | – | + | + | – | ||
| 4 | – | + | + | |||
| 5 | – | + | ||||
| 6 | – |
Groups: {1, 3, 6}, {2, 4}, {5} → three genes.
Exceptions that Part C uses
| Exception | What happens | Why |
|---|---|---|
| Dominant mutations | Cannot be tested: the heterozygote is mutant whatever the other mutation is | The test needs recessive alleles |
| Intragenic (interallelic) complementation | Two mutations in one gene give partial wild-type activity in trans | The product is a multimer; differently defective subunits can correct each other in a hybrid protein. Usually incomplete and allele-specific |
| Non-allelic non-complementation | Mutations in different genes fail to complement | Products are partners in one complex, or the double heterozygote halves two limiting doses; often allele-specific (a “poison” subunit) |
| Polar mutations | A nonsense or insertion mutation in an upstream gene of an operon fails to complement a mutation in a downstream gene | Reduced expression of downstream genes in the same transcript |
| Deletions | Fail to complement every gene they remove | They are missing several genes at once |
Kinds of Mutation
By the change in DNA
| Class | Change | Note |
|---|---|---|
| Transition | Purine ↔ purine or pyrimidine ↔ pyrimidine (A·T ↔ G·C) | 4 possible of the 12 single-base changes; more frequent in practice |
| Transversion | Purine ↔ pyrimidine (e.g. G·C → T·A) | 8 possible |
| Insertion / deletion (indel) | Gain or loss of one or more bases | If not a multiple of 3 in a coding region → frameshift |
| Dynamic mutation | Expansion of a trinucleotide (or other) repeat | Unstable between generations; anticipation (fragile X, Huntington disease) |
| Large rearrangements | Deletions, duplications, inversions, translocations | See Chromosomal Alterations and Recombination |
| Insertion of a transposable element | Interrupts a gene or its control region | Many spontaneous mutations in Drosophila and maize |
By the effect on the protein
| Class | Effect | Example |
|---|---|---|
| Silent (synonymous) | Codon changes, amino acid does not | Usually third-position changes; can still matter if they alter splicing or codon usage |
| Missense | One amino acid replaced | Conservative (similar side chain) or non-conservative; sickle-cell Glu6Val |
| Nonsense | Sense codon → stop: amber UAG, ochre UAA, opal (umber) UGA | Truncated protein; in eukaryotes often nonsense-mediated decay |
| Frameshift | Reading frame shifted downstream | Usually a premature stop soon after |
| Neutral | Amino acid changes but function does not | — |
| Regulatory / splice-site | Promoter, enhancer or splice-junction changes | β-thalassaemias include many splice-site mutations |
By the effect on function (Muller’s morphs)
| Muller’s class | Effect | Genetic test with a deletion (Df) or extra copies | Dominance |
|---|---|---|---|
| Amorph (null) | No function | m/Df = m/m | Usually recessive |
| Hypomorph | Reduced function | m/Df more severe than m/m | Usually recessive |
| Hypermorph | Increased function of the normal kind | Extra wild-type copies mimic it | Often dominant |
| Antimorph | Antagonises the wild-type product (dominant negative) | Extra wild-type copies reduce the phenotype | Dominant |
| Neomorph | New function (e.g. ectopic expression or new activity) | Unaffected by the dosage of wild-type copies | Dominant |
In modern language: loss-of-function (LOF) = amorph and hypomorph; gain-of-function (GOF) = hypermorph and neomorph; dominant-negative = antimorph.
Other operational classes
- Conditional (temperature-sensitive, cold-sensitive): mutant only under the restrictive condition; essential genes can be studied this way.
- Auxotrophic (needs a supplement the wild-type prototroph does not); resistance mutations; lethal mutations.
- Forward mutation (wild type → mutant) is much more frequent than reverse mutation (mutant → wild type), because there are many ways to destroy a function and few ways to restore it.
- Reversion can be true (original sequence restored) or suppression: an intragenic suppressor (second site in the same gene, e.g. a compensating frameshift of opposite sign) or an intergenic suppressor (another gene, e.g. a tRNA whose anticodon now reads a stop codon). Amber suppressors read UAG only; ochre suppressors read UAA and UAG (by wobble).
- Germline mutations are heritable; somatic mutations affect only the descendants of the mutated cell (mosaics, cancers).
Why Mutations Are Dominant or Recessive
Most LOF mutations are recessive because one functional copy makes enough product. Three mechanisms make a mutation dominant:
| Mechanism | Logic | Example |
|---|---|---|
| Haploinsufficiency | 50% of the product is not enough for the normal phenotype | Notch in Drosophila (heterozygotes have notched wings); Minute (ribosomal protein) mutations |
| Gain of function | The mutant product does something more or something new | Constitutively active Ras (e.g. G12V) in tumours; FGFR3 mutation in achondroplasia; dominant Antennapedia alleles (ectopic expression → legs in place of antennae) |
| Dominant negative | The mutant product interferes with the wild-type product made in the same cell | See below |
Dominant-negative mutations
A dominant-negative mutant protein retains the ability to interact (bind a partner, form an oligomer, bind DNA) but has lost its activity, so it poisons complexes that also contain wild-type subunits. The heterozygote is more severely affected than a heterozygote for a null allele.
Quantitative logic. If a protein acts as a homo-oligomer of n subunits and wild-type and mutant subunits are made in equal amounts and assemble at random, the fraction of fully wild-type (active) complexes is
$$f = \left(\tfrac{1}{2}\right)^{n}$$| Oligomer | Active fraction in a heterozygote (dominant-negative) | Null heterozygote |
|---|---|---|
| Monomer | 50% | 50% |
| Dimer | 25% | 50% |
| Tetramer | 6.25% | 50% |
Examples: missense mutations in p53, which acts as a tetramer, can inactivate the wild-type subunits; glycine substitutions in type I collagen (COL1A1) disrupt the triple helix and cause more severe osteogenesis imperfecta than null alleles of the same gene, which simply halve collagen; kinase-dead receptor tyrosine kinases block signalling by forming inactive dimers with wild-type receptors. Experimentally, over-expressing a dominant-negative construct is a standard way to block a pathway in cells.
Causes of Mutation
Spontaneous mutations
| Source | Lesion | Mutation |
|---|---|---|
| Replication errors (tautomeric shifts) | Rare imino or enol forms mispair (e.g. enol-T with G) | Transitions |
| Strand slippage in repeats | Loop-out of the template or new strand | Small insertions/deletions, frameshift hotspots in runs |
| Deamination of cytosine | C → U | G·C → A·T (normally removed by uracil-DNA glycosylase) |
| Deamination of 5-methylcytosine | 5mC → T | G·C → A·T; CpG sites are mutational hotspots, because T is a normal base and the T·G mismatch is repaired less efficiently |
| Depurination | AP site | Can give any base; often a transversion after bypass synthesis |
| Oxidative damage | 8-oxoguanine pairs with A | G·C → T·A transversion |
| Transposable elements | Insertion | Gene disruption, polar effects |
Induced mutations: mutagens and their signatures
| Mutagen | Mode of action | Typical change |
|---|---|---|
| 5-Bromouracil | Thymine analogue; its keto form pairs with A, its enol (and ionised) form pairs with G | A·T ↔ G·C transitions (both directions) |
| 2-Aminopurine | Adenine analogue; pairs with T, occasionally with C | Transitions (both directions) |
| Nitrous acid | Oxidative deamination: A → hypoxanthine (pairs with C), C → U (pairs with A); G → xanthine (still pairs with C) | Transitions both ways |
| Hydroxylamine | Hydroxylates the amino group of C; modified C pairs with A | G·C → A·T only |
| EMS, MMS, nitrosoguanidine (alkylating agents) | Alkylate G (O⁶-alkylguanine pairs with T) and other positions | Mainly G·C → A·T; also depurination and some transversions |
| Acridines (proflavin, acridine orange), ethidium bromide | Intercalate between base pairs, causing slippage | ±1 frameshifts (the mutagen behind the rIIB frameshift experiments that showed the code is read in triplets) |
| UV light | Cyclobutane pyrimidine dimers and 6–4 photoproducts at adjacent pyrimidines | C → T transitions and CC → TT tandem changes at dipyrimidine sites, largely via error-prone (SOS) bypass in E. coli |
| Ionising radiation (X-rays, γ-rays) | Free radicals; single- and double-strand breaks | Deletions and chromosome rearrangements; H. J. Muller showed X-rays induce mutations in Drosophila |
| Aflatoxin B₁, benzo[a]pyrene (after metabolic activation) | Bulky adducts on guanine | G·C → T·A transversions |
Using reversion to classify a mutation
Whether a mutagen can revert a mutation tells you what the original change was:
- A mutation induced by 5-BU or 2-AP (a transition) can be reverted by 5-BU, 2-AP or nitrous acid.
- Hydroxylamine converts only G·C → A·T, so it can revert only a mutation that created a G·C pair where the wild type had A·T (an A·T → G·C mutation).
- A mutation induced by proflavin (frameshift) is not reverted by base analogues, but is reverted by proflavin (often by a compensating frameshift of opposite sign nearby).
- A mutation that never reverts is likely a deletion (Benzer used this criterion).
Detecting Mutations
| Method | System | What it detects |
|---|---|---|
| Fluctuation test (Luria and Delbrück) | E. coli, phage T1 resistance | That mutations arise before selection; also gives the mutation rate |
| Replica plating (J. and E. Lederberg) | Bacteria | Resistant colonies at identical positions on replicas never exposed to the agent → pre-existing mutants; also used to screen auxotrophs |
| Ames test | Salmonella typhimurium his⁻ strains | Reversion to His⁺ as a measure of mutagenicity |
| ClB method (Muller) | Drosophila | X-linked recessive lethals |
| Muller-5 (Basc) | Drosophila | X-linked lethals and visibles; homozygous females viable |
| Attached-X | Drosophila | X-linked visible mutations in males |
| TILLING | Plants and animals mutagenised with EMS | Point mutations in a chosen gene, by mismatch cleavage (e.g. CEL I nuclease) of heteroduplex PCR products |
| Sequencing (Sanger, next-generation) | Any | Direct identification |
Ames test
- Tester strains carry different his mutations: TA100 detects base-substitution mutagens; TA98 detects frameshift mutagens.
- Extra changes increase sensitivity: a uvrB deletion (no NER, so lesions persist), an rfa mutation (defective lipopolysaccharide, so large molecules enter the cell), and plasmid pKM101 (error-prone repair genes).
- A rat-liver S9 fraction (microsomal enzymes) is added to convert promutagens into active mutagens, mimicking mammalian metabolism.
- Read-out: His⁺ revertant colonies on minimal medium compared with the spontaneous background; a dose-dependent increase indicates a mutagen. Many mutagens detected this way are also carcinogens, which is the reason for the test.
ClB method
The ClB X chromosome carries C (a large inversion that suppresses recovery of crossovers), l (a recessive lethal) and B (Bar eyes, a visible marker).
graph TD
A["P: ClB/+ female × irradiated male (X*)"] --> B["F1: pick Bar-eyed daughters
ClB / X*"]
B --> C["Cross each to a normal male"]
C --> D["F2 sons: ClB/Y die (l);
X*/Y survive only if X* has no lethal"]
D --> E["No sons in F2 → new X-linked
recessive lethal on X*"]Normal F₂ sex ratio is 2 females : 1 male (half the sons die because of l); a culture with no males reveals a new lethal. The frequency of such cultures estimates the X-linked lethal mutation rate.
The fluctuation test as a rate calculation
If mutations are random and rare, the number of mutational events per culture is Poisson distributed with mean m. The fraction of cultures with no mutants is
$$P_0 = e^{-m} \quad\Rightarrow\quad m = -\ln P_0$$and the mutation rate per cell per generation is approximately m / N, where N is the number of cells in a culture at the end of growth (the number of cell divisions). This “P₀ method” is the simplest one asked in exams.
Mutation Rate vs Mutation Frequency
| Definition | Depends on | |
|---|---|---|
| Mutation rate | Probability of a mutational event per gene (or per base) per cell division or per generation | The mutational process only |
| Mutation frequency | Proportion of mutant cells or individuals in a population | Rate, plus timing (jackpots), growth and selection |
Fine-Structure Mapping: Benzer and the rII Locus
Seymour Benzer (1950s) used phage T4 to map mutations within one gene at a resolution down to adjacent base pairs. The trick was a selective system in which a vanishingly rare recombinant could be detected among millions of progeny.
The system
| Phage | On E. coli B | On E. coli K12(λ) |
|---|---|---|
| Wild type (r⁺) | Small, fuzzy plaques | Grows |
| rII mutant | Large, sharp-edged plaques (rapid lysis) | Cannot grow |
Step 1: complementation defines two cistrons
Co-infect K12(λ) with two rII mutants. If the cells lyse, the mutants complement (different cistrons). Benzer found two complementation groups, rIIA and rIIB: the original operational definition of a cistron.
Step 2: recombination maps sites within a cistron
Co-infect E. coli B (permissive) with two rII mutants of the same cistron; progeny include rare r⁺ recombinants.
- Plate a diluted sample on B → total progeny.
- Plate a less-diluted sample on K12(λ) → only r⁺ recombinants grow.
- Because the reciprocal double-mutant recombinant is as frequent as r⁺ but invisible on K,
Remember to multiply each plaque count by its own dilution factor before dividing.
Step 3: deletion mapping for speed
Some rII mutations never revert and fail to recombine with several different point mutations: they are deletions. Using a set of overlapping deletions:
- A point mutation that gives no r⁺ recombinants with a deletion lies within the deleted region.
- A point mutation that does give recombinants lies outside it.
Testing a new mutation against a nested set of deletions places it in a small segment with a few crosses; only then are point-by-point crosses needed.
| Deletion D1 | Deletion D2 | Deletion D3 | |
|---|---|---|---|
| Region covered | Segments 1–4 | Segments 3–6 | Segments 5–8 |
| Mutant X: recombinants? | No | No | Yes |
| → X lies in segment | 3 or 4 (inside D1 and D2, outside D3) |
What the rII work showed
- A gene is divisible by recombination: recombination can occur between mutations at different sites within it, with the smallest frequencies consistent with exchange between adjacent base pairs.
- The map within the gene was linear, consistent with DNA being a linear molecule.
- Mutations were not uniformly distributed: some sites (hotspots) mutated spontaneously far more often than others, and different mutagens had different hotspots.
- It replaced the old “bead” concept of the gene with three units:
| Benzer’s unit | Definition | Modern equivalent |
|---|---|---|
| Cistron | Unit of function (complementation) | Gene (coding region plus what is needed for its function) |
| Recon | Smallest unit of recombination | One base pair |
| Muton | Smallest unit of mutation | One base pair |
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| Complementation: function test, needs trans configuration and recessive alleles | vs | Recombination: physical exchange; gives new genotypes even within one gene |
| Allele (same locus) | vs | Pseudoallele (fails to complement but separable by crossing over) |
| Transition (purine ↔ purine) | vs | Transversion (purine ↔ pyrimidine) |
| Amber UAG | vs | Ochre UAA and opal/umber UGA |
| Haploinsufficiency: half dose not enough | vs | Dominant negative: mutant protein poisons wild-type protein |
| Base analogue: incorporated during replication | vs | Base modifier: chemically changes bases already in DNA |
| Mutation rate (events per division) | vs | Mutation frequency (fraction of mutants present) |
| Intragenic suppressor (second site, same gene) | vs | Intergenic suppressor (another gene, e.g. suppressor tRNA) |
| Cistron (function) | vs | Recon / muton (recombination / mutation, one base pair) |
Common Mistakes
Practice
All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.
Level 1: Foundation
- Which mutagen converts G·C to A·T only, and can be used on free phage particles?
- In a complementation test, the trans heterozygote shows a wild-type phenotype. What do you conclude?
- Which stop codon is called ochre?
Answers
- Hydroxylamine (it modifies cytosine in existing DNA, so replication is not needed for the chemical change).
- The two mutations are in different genes (they complement).
- UAA.
Level 2: Part B Style
Q1 (practice). A transcription factor binds DNA as a tetramer. A heterozygote carries one wild-type allele and one allele encoding a protein that oligomerises normally but cannot activate transcription. Both alleles are expressed equally and subunits assemble at random. The fraction of fully active tetramers is closest to:
- (a) 50%
- (b) 25%
- (c) 12.5%
- (d) 6.25%
Answer and explanation
(d). Only all-wild-type tetramers are active: \((1/2)^4 = 1/16 = 6.25\%\). (a) is the expectation for a null (non-assembling) allele; (b) would apply to a dimer.
Q2 (practice). A nonsense mutation in gene X of E. coli is suppressed by a mutant tRNA that also suppresses a known UAG mutation in another gene, but not a known UAA mutation. The suppressor is best described as:
- (a) an ochre suppressor; the X mutation is UAA
- (b) an amber suppressor; the X mutation is UAG
- (c) an intragenic suppressor
- (d) a frameshift suppressor
Answer and explanation
(b). A tRNA that reads UAG but not UAA is an amber suppressor, so the suppressible X mutation is UAG. Ochre suppressors read both UAA and UAG. It is intergenic (a tRNA gene), not intragenic.
Q3 (practice). Six recessive mutants with the same phenotype are tested pairwise in trans; – means mutant (no complementation). Pairs giving –: 1–3, 1–6, 3–6, 2–4. All other pairs give wild type. How many genes are represented?
- (a) 2
- (b) 3
- (c) 4
- (d) 6
Answer and explanation
(b) 3. Groups: {1, 3, 6}, {2, 4}, {5}. Mutant 5 complements every other mutant, so it is a gene of its own.
Q4 (practice). A his⁻ mutation of Salmonella is reverted efficiently by 2-aminopurine but not by proflavin. Revertants are also obtained when DNA carrying the mutation is treated with hydroxylamine in vitro and introduced into cells by transformation. The original mutation most likely:
- (a) changed an A·T pair to a G·C pair
- (b) changed a G·C pair to an A·T pair
- (c) was a +1 frameshift
- (d) was a deletion of several base pairs
Answer and explanation
(a). Reversion by 2-AP means a transition (not a frameshift or deletion). Hydroxylamine only converts G·C → A·T, so for it to restore wild type the mutant site must now carry G·C where wild type had A·T; that is, the original mutation was A·T → G·C.
Level 3: Part C Style
Q1 (practice). Fifty parallel cultures of a bacterium, each grown from a small inoculum to 2 × 10⁸ cells, are plated on medium containing a phage. Twenty cultures give no resistant colonies; the others give counts ranging from 1 to 210, with a variance many times the mean.
(i) What does the large variance show? (ii) Estimate the mutation rate to resistance by the P₀ method. (iii) Why would plating 50 samples from one large culture give a different variance?
Answer and worked solution
(i) The counts are not Poisson (variance ≫ mean): mutations arose at different times during growth, before exposure to phage, and early mutations produced large clones (jackpots). Resistance is not induced by the phage.
(ii) \(P_0 = 20/50 = 0.4\); \(m = -\ln 0.4 = 0.916\) mutations per culture. Rate \(\approx m/N = 0.916 / (2 \times 10^8) \approx 4.6 \times 10^{-9}\) per cell per generation.
(iii) Samples from one culture share the same history of jackpots, so they differ only by sampling error: variance ≈ mean (Poisson). That control is what makes the comparison decisive.
Q2 (practice). Two rIIA point mutants of T4 are crossed by mixed infection of E. coli B. A 10⁻⁷ dilution of the lysate plated on E. coli B gives 160 plaques; a 10⁻³ dilution of the same lysate plated (same volume) on E. coli K12(λ) gives 64 plaques. Which statements are correct?
(P) The recombination frequency between the two sites is 0.008%. (Q) The recombination frequency is 0.004%, since only r⁺ plaques were counted. (R) If the two mutants were in different cistrons, the K12(λ) plate would show many more plaques because of complementation during the cross. (S) If one mutant were a deletion covering the other site, no plaques would be expected on K12(λ) beyond those from reversion.
- (a) P and S only
- (b) Q and S only
- (c) P, R and S
- (d) Q and R only
Answer and worked solution
(a) P and S only.
Total progeny titre ∝ 160 × 10⁷ = 1.6 × 10⁹; r⁺ titre ∝ 64 × 10³ = 6.4 × 10⁴. RF = 2 × 6.4 × 10⁴ / 1.6 × 10⁹ = 8 × 10⁻⁵ = 0.008%. (P) correct; (Q) forgets the factor of 2.
(R) is wrong: the progeny lysate is plated on K12(λ), where each plaque starts from a single phage; a single rIIA or rIIB mutant cannot grow there whether or not the parents could complement. Complementation is tested by co-infecting K12(λ), not by plating progeny. (S) correct: a deletion overlapping the point mutation cannot recombine with it to give r⁺.
Q3 (practice). A new Drosophila mutation m causes small eyes. It is compared with a known null allele n of the same gene, a deficiency Df removing the gene, and a duplication Dp(+) carrying one extra wild-type copy:
| Genotype | Eye size |
|---|---|
| +/+ | Normal |
| n/+ and Df/+ | Normal |
| n/n | Very small |
| m/+ | Small |
| m/+/Dp(+) | Nearly normal |
| m/m and m/Df | Very small (same as n/n) |
Classify m by Muller’s scheme and justify each line.
Answer and worked solution
m is an antimorph (dominant negative).
- n/+ and Df/+ are normal, so the gene is not haploinsufficient: the dominance of m/+ is not caused by losing one dose.
- m/+ is abnormal, but adding a wild-type copy (m/+/Dp) restores nearly normal eyes: the mutant product antagonises the wild-type product, and extra wild type out-competes it.
- With no wild-type product present (m/m, m/Df), m behaves exactly like the null: an inactive protein has nothing left to poison.
- Excluded: amorph/hypomorph (would be recessive here, since half dose is enough); hypermorph (extra wild type would make it worse, not better); neomorph (a new function would not be suppressed by extra wild type, and m/m would not simply copy the null).
Quick Revision Table
| Item | Fact |
|---|---|
| Pseudoalleles | Fail to complement in trans, separable by recombination; cis–trans position effect (lozenge, Star–asteroid, bithorax) |
| Complementation | Trans, recessive alleles; wild type → different genes; defines the cistron |
| Exceptions | Intragenic complementation (multimers), non-allelic non-complementation, polarity, deletions |
| Transitions / transversions | 4 / 8 of 12 possible single-base changes |
| Stop codons | Amber UAG, ochre UAA, opal/umber UGA; ochre suppressors read UAA + UAG |
| Muller’s morphs | Amorph, hypomorph, hypermorph, antimorph (dominant negative), neomorph |
| Dominance mechanisms | Haploinsufficiency, gain of function, dominant negative |
| Dominant negative, n-mer | Active fraction \((1/2)^n\); p53 tetramer, collagen OI |
| Spontaneous | Tautomers, slippage, C → U, 5mC → T (CpG hotspots), depurination, 8-oxoG → G·C → T·A |
| Base analogues | 5-BU, 2-AP: transitions both ways; need replication |
| Base modifiers | HNO₂ (deamination, both ways); NH₂OH (G·C → A·T only); EMS (G·C → A·T) |
| Intercalators | Acridines, EtBr: ±1 frameshifts |
| UV / X-rays | Pyrimidine dimers (C → T) / breaks, deletions, rearrangements |
| Fluctuation test | Luria–Delbrück 1943; variance ≫ mean; \(m = -\ln P_0\); rate ≈ m/N |
| Replica plating | Lederbergs; pre-existing resistant mutants |
| Ames test | his⁻ Salmonella; TA98 frameshift, TA100 base substitution; uvrB, rfa, pKM101; S9 |
| ClB | C inversion, l lethal, B Bar; no F₂ males → new X-linked lethal |
| rII system | Large plaques on B; no growth on K12(λ); RF = 2 × r⁺/total |
| Deletion mapping | No r⁺ with a deletion → point mutation lies inside it; non-reverting |
| Benzer’s units | Cistron (function), recon and muton (one base pair) |
Key Takeaways
What’s Next
- Genetic Mapping: Linkage, Tetrads, Bacteria and Markers — mapping between genes in eukaryotes, fungi and bacteria, and the markers used today.
- Chromosomal Alterations and Recombination — mutations large enough to see under the microscope.
- Human Genetics: Pedigrees, LOD Scores, Karyotypes and Disorders — trinucleotide expansions, dominant negatives and haploinsufficiency in human disease.
- DNA Replication, Repair and Recombination — the repair pathways that decide which lesions become mutations.